Skip to main content
. 2020 May 23;59(16):1983–1989. doi: 10.2169/internalmedicine.4437-20

Table 1.

Clinical Data of UC Patients with Esophageal Ulcer.

Case
(No)
Ref
No.
Age
(yrs)
Sex Duration
of UC
UC phase Type UC treatment
1 Ours 16 F 0 Active Total PSL
2 Ours 19 F 0 Active Total PSL
3 6 15 M 2 years Remission Left side PSL, SASP
4 7 23 M 5 years Remission Total PSL, SASP
5 8 21 F 0 Active N/A PLS, SASP
6 19 M 0 Active N/A N/A
7 10 47 F 0 Active Right side 5ASA
8 4 18 F 7 years Relapse Active Total SASP
9 11 18 M 1 year Active Left side PSL, 5ASA
10 12 19 M 0 Active Total none
11 13 51 M 0 Active Total PSL, 5ASA
12 14 33 M 0 Active Total PSL, LCAP
13 15 52 F 3 years Relapse Active Left side SASP
14 5 28 M 17 years Post operation Total Total colectomy and ileostomy
15 8 26 M 2 months Post operation Total Sbtotal colectomy and ileostomy
16 14 F 5 years Post operation Total Sbtotal colectomy and ileostomy
17 24 M 9 years Post operation Total Total proctocolectomy
18 9 21 M 3 years Post operation Total Total colectomy and ileostomy
19 16 47 M 21 years Post operation N/A Sbtotal colectomy and ileostomy
20 53 M N/A Post operation Total Sbtotal colectomy

UC: ulcerative colitis, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, F: female, M: male